Eliminates false positives from methicillin-resistant CoNS (coagulase-negative staphylococci)
Available in 50-test and 200-test kits
Significantly reduces hands-on time
Approval
US FDA
Product Number
MRSS1-100N-050
Method
Real-Time PCR
Sample
Nasal swab
Instrumentation Needed
The IDI-MRSA test is designed specifically for use on the Cepheid SmartCycler® System.
Incubation/Processing Time
Results in less than 2 hours
Pricing
Related Content
Product Description
IDI-MRSA™ is the first diagnostic test cleared by the FDA and by Health Canada for the direct detection of nasal colonization by methicillin resistant Staphylococcus aureus (MRSA). Based on the real-time PCR technology, IDI-MRSA™ test results are available in about one hour after the collection of a nasal swab, compared to other methods that require two to five days. By detecting a single genetic sequence specific of MRSA, the IDI-MRSA™ assay provides a full response in a single step.
With its unique features, IDI-MRSA™ provides a key tool for the control and prevention of MRSA infections.
NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary.
